Doyle Mittie
Chief Medical Officer
Doyle Mittie has filed 7 SEC Form 4 filings (21 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.4M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| AVTX | Chief Medical Officer | Sale | 4,654 | $93K | Jul 2 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 1,450 | $26K | Jun 25 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 679 | $11K | Jun 1 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 3,000 | $56K | May 19 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 1,679 | $27K | May 7 | SEC ↗ | |
| AVTX | Chief Medical Officer | Sale | 106,555 | $2.2M | May 7 | SEC ↗ |